ClinicalTrials.gg
Status unknownNCT05665933Updated Jan 5, 2023

Acceptance and Commitment Therapy and Test Anxiety

An interventional study of ACCEPTANCE AND COMMITMENT THERAPY-BASED PSYCOEDUCATION in Therapy, Directly Observed, sponsored by Artvin Coruh University. Status unknown at 2 sites in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2023-01-05.

Sponsored by Artvin Coruh University · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Sex
All
01

Study summary

The aim of this study is to evaluate the effect of acceptance and commitment therapy-based psychoeducation on test anxiety, study skills and psychological flexibility on adolescents. test anxiety scale, study skills scale and psychological flexibility scale are data collection tools. The pretest-posttest is a randomized controlled trial. Experimental and control groups were formed. A 6-week psychoeducation will be applied to the experimental group.

Read the detailed description

The aim of this study is to determine the effect of acceptance and commitment therapy-based psychoeducation given to adolescents on test anxiety, study skills and psychological flexibility.The research was designed as a randomized controlled study with pretest, posttest, experimental and control groups aiming to examine the results of Acceptance and Commitment Therapy (ACT) based psychoeducation for test anxiety and study skills. The number of effects of the study was targeted by the randomization method among the adolescents who met the inclusion criteria and accepted the application. In the power analysis, the evaluation of the number of increase is aimed at 0.05 aggression level at the 95% confidence interval, and 52 adolescents, 26 experimental and 26 control groups, to reach 80% power. Randomization methods were used so that individuals could be assigned to the experimental groups with equal chance, similar to the scores they obtained from the laboratory test anxiety periods. 52 adolescents who met the clinical research criteria for randomization were divided into 2 groups using the irregular numbers table, this group was named as the experimental and control groups by drawing lots. The group that came out first in the lottery at this stage was accepted as the experimental group. Psychoeducation is planned to be held between December 2022 and February 2023.

02

Conditions studied

  • Therapy, Directly Observed

Keywords

  • acceptance and commitment therapy
  • test anxiety
  • study skills
  • psychological flexibility
03

In context

Directly Observed Therapy

34 studies on the registry are indexed under Directly Observed Therapy; 4 are open to participants now.

This study's planned enrollment of 60 is below the median of 121 across 34 interventional studies indexed under Directly Observed Therapy.

Browse Directly Observed Therapy studies →

Lead sponsor

Artvin Coruh University is the lead sponsor of 29 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Students' willingness to participate in research
  • Students being 11th graders
  • Getting a score of 50 or more on the test anxiety scale

Exclusion criteria

Exclusion Criteria:

  • Any degree of cognitive decline or impairment
  • Presence of depressive disorder
  • Presence of serious psychiatric disorder
  • Being under treatment for a psychiatric condition
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    THE EFFECT OF ACCEPTANCE AND COMMITMENT THERAPY-BASED PSYCOEDUCATION

    PSYCHOEDUCATION PROGRAM Total Duration: 6 Weeks Session Duration: 90 min Frequency: 1 day per week Number of People: 30

    Behavioral: ACCEPTANCE AND COMMITMENT THERAPY-BASED PSYCOEDUCATION

  • No intervention
    THE EFFECT OF ACCEPTANCE AND COMMITMENT THERAPY-BASED PSYCOEDUCATION ON EXAM ANXIETY IN ADOLESCENTS

    Similar training will be provided after the study is completed. Number of People: 30

Interventions

  • BehavioralACCEPTANCE AND COMMITMENT THERAPY-BASED PSYCOEDUCATION

    Total Duration: 6 Weeks Session Duration: 90 min Frequency: 1 day per week Number of People: 30

06

What researchers measure

Primary outcomes

  1. Change of Exam Anxiety Scale Total Score

    Change in test anxiety scale at the end of 6 weeks. The highest score from the test anxiety scale is 80 and the lowest score is 20. A high score defines high anxiety.

    Time frame: 6 weeks

  2. Change study skills in adolescents.

    Change in test study skills scale.A maximum of 165 and a minimum of 55 points are obtained from the study skills scale. A high score defines the ability to study effectively.

    Time frame: 6 weeks

Secondary outcomes

  1. Change the level of psychological flexibility

    Change in test psychological flexibility. A maximum of 196 and a minimum of 28 points are obtained from the psychological flexibility scale. A higher score reflects higher psychological flexibility.

    Time frame: 6 weeks

07

Study locations

2 of 2 sites recruiting
  • ArtvinCoruhU
    Artvın, Center, Turkey (Türkiye)
    Recruiting
    • Kubra Tan, Master · Contactkubratan@artvin.edu.tr · +90 0466 215 1000
    • Ayşe Okanlı · Contact
    • Kubra TAN, Master · Principal investigator
    • Ayşe Okanlı, Prof.Dr. · Sub investigator
  • ArtvinCoruhU
    Artvın, Turkey (Türkiye)
    Recruiting
    • Kubra Tan, Master · Contactkubratan@artvin.edu.tr · +90 0466 215 1000
    • Ayşe Okanlı · Contact
    • Kubra TAN, Master · Principal investigator
    • Ayşe Okanlı, Prof.Dr. · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — The name and results of the study will be shared.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05665933
Lead sponsor
Artvin Coruh University
Responsible party
Kubra Tan (Lecturer, Artvin Coruh University) — Principal investigator
First posted
Dec 27, 2022
Start date
Dec 1, 2022
Primary completion
Dec 15, 2022
Completion
Jul 2023 (estimated)
Last update
Jan 5, 2023

Study contacts

Kübra Tan, Master
Contact
tankubra@hotmail.com
+90 5544339729
Ayşe Okanlı, Prof. Dr.
Contact
a.okanli@gmail.com
+90 5423787828
Kübra Tan
study director · https://www.artvin.edu.tr/kubra-tan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion